Pierre-Charles-Alexandre Louis
1787 - 1872 · Franzose · Klinische Medizin
Französischer Arzt, dessen numerische Methode der klinischen Statistik — angewandt auf die Aderlasspraktiken seiner Zeit — die quantitativen Belege gegen die Blutegelmanie der Broussais-Ära lieferte, die zum Rückzug von der wahllosen Phlebotomie Mitte des neunzehnten Jahrhunderts beitrugen.
Profil
- Lebensjahre
- 1787 - 1872
- Nationalität
- French
- Epoche
- 19. Jahrhundert
- Hauptfachgebiet
- Klinische Medizin
Institutionelle Zugehörigkeiten
- Hôpital de la Charité, Paris (chief of clinical service)
- Hôtel-Dieu de Paris (clinical service)
- Société Médicale d'Observation, Paris (founder)
- University of Paris Medical Faculty
Wichtige Beiträge
- Pioneered the application of systematic numerical-statistical methods to clinical medicine, comparing outcomes among groups of patients treated with different therapies — a foundational step toward the modern controlled clinical trial.
- Published Recherches sur les effets de la saignée (1835), an analysis of patient outcomes in pneumonia under aggressive versus conservative bloodletting that found no benefit to aggressive phlebotomy and contributed to the decline of Broussais-era leech mania in French medicine.
- Founded the Société Médicale d'Observation in Paris, training a generation of French and American physicians in the numerical method, including Oliver Wendell Holmes Sr. and James Jackson Jr.
- Worked at La Charité and other Parisian hospitals during the peak decades of therapeutic bloodletting, providing his quantitative work with direct clinical relevance to the prevailing practice.
- His work was a key intellectual source of the broader mid-nineteenth-century retreat from heroic bloodletting in European and North American medicine, which eventually narrowed the indications for therapeutic leech application toward the localized surgical uses that survive in modern microsurgical practice.
Bedeutung für die Hirudotherapie
Pierre-Charles-Alexandre Louis is the principal figure in the nineteenth-century methodological turn toward quantitative clinical evidence in European medicine, and his work bears directly on the history of leech therapy because it provided the empirical evidence against which the peak-era Broussais leech mania ultimately could not stand. Working at the Hôpital de la Charité in Paris during the very decades in which Broussais's physiological medicine doctrine was driving annual French leech consumption to tens of millions, Louis applied a systematic numerical method to the clinical outcomes of his pneumonia patients, comparing groups treated with aggressive bloodletting against groups treated with conservative regimens. The central finding of Louis's 1835 Recherches sur les effets de la saignée — that aggressive phlebotomy did not improve outcomes in pneumonia, and may have worsened them — directly contradicted the central therapeutic claim of Broussais's school and contributed to the rapid collapse of the leech-mania doctrine in French medicine during the 1840s and 1850s. The decline was not solely attributable to Louis; it also reflected the rise of cellular pathology under Virchow, the discrediting of humoral theory more broadly, and the emergence of new therapeutic alternatives. But Louis's numerical method provided a methodological framework within which the empirical inadequacy of aggressive phlebotomy could be demonstrated rather than merely asserted. The American Society of Hirudotherapy regards Pierre-Charles-Alexandre Louis as the methodological ancestor of the modern evidence-based clinical evaluation of leech therapy. The line from Louis's 1835 numerical comparison of bloodletting outcomes to the modern randomized controlled trials of leech application in knee osteoarthritis (Michalsen et al., Lauche et al.) is a continuous methodological lineage, even though the specific clinical questions being asked have changed entirely. Louis's contribution to hirudotherapy is paradoxical: his work helped end the era of indiscriminate leech use, but in doing so it laid the foundation for the disciplined evidence-based revival of medicinal leech application within the narrower indications where the procedure can be shown to be genuinely beneficial.
Wichtige Publikationen
- Recherches sur les effets de la saignée dans quelques maladies inflammatoires · Paris: J.-B. Baillière (1835)
- Recherches anatomico-pathologiques sur la phthisie · Paris: Gabon (1825)
- Recherches sur la fièvre typhoïde · Paris: J.-B. Baillière (1829)
Externe Ressourcen
Beeinflusste Forschung
Verbindungen und Forschungsbereiche, die auf die Beiträge dieser Persönlichkeit zurückgehen:
Verwandte Persönlichkeiten
John Berry Haycraft
1857-1922 · Brite (Schotte)
Edinburgh-Physiologe, der 1884 Hirudin entdeckte und die moderne Molekularpharmakologie des Blutegelspeichels begründete.
Marie Termier
1859-1930 · Franzose
Französische Ärztin, die 1922 eine der ersten formalen klinischen Studien zur Blutegeltherapie bei postoperativer Thrombose veröffentlichte und damit die moderne klinische Methodik in der Hirudotherapie etablierte.
Andreas Michalsen
1961- · Deutscher
Integrativmedizinischer Arzt an der Charité Berlin, dessen 2003 in den Annals of Internal Medicine veröffentlichter RCT zu Kniegelenkarthrose die wegweisende Studie wurde, die die Hirudotherapie in Cochrane-Reviews und moderne Leitlinien der Integrativen Medizin einbrachte.
Sabine Andereya
1968- · Deutscher
Aachener orthopädischer Chirurg, dessen RCTs von 2006 und 2008 zu symptomatischer Karpometakarpalarthrose die Blutegeltherapie als wirksam bei Handarthrose der kleinen Gelenke validierten — die zweite bewiesene Indikation in der modernen Hirudotherapie.